COMP <GO>
TRVI vs XERS // ENTERPRISE SCALE & MARKET CAP
Trevi Therapeutics Inc. (NASDAQ) VS. Xeris Biopharma Holdings Inc. (NASDAQ) • 15-METRIC TALLY: TRVI 1
— XERS 4
▲ ENTERPRISE SCALE & MARKET CAP LEADER: TRVI
LAST: $13.81 (+2.15%) • MKT CAP: $1.97B
market-cap
$1.97B
LAST: $10.75 (+1.03%) • MKT CAP: $1.96B
market-cap
$1.96B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TRVI VS. XERS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TRVI | XERS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -23.70% | 16.00% | -39.70 | XERS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 83.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.14% | 1.46% | -3.60 | XERS | /fcf-yield <GO> |
| Operating Margin | — | 8.50% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 0.20% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 43.70% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 2.11 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | XERS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.7 | 60.5 | -6.80 | XERS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $1.97B | $1.96B | $7.6M | TRVI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TRVI REV | XERS REV | TRVI GROSS % | XERS GROSS % | TRVI FCF | XERS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $291.8M | — | — | -$42.1M | $28.6M |
| FY 2024 | $0 | $203.1M | — | — | -$38.3M | -$37.0M |
| FY 2023 | $0 | $163.9M | — | — | -$31.7M | -$47.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TRVI // BETA —
XERS // BETA —